BEVERLY HILLS, Calif., July 9, 2015 (GLOBE NEWSWIRE) -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, received an endorsement of its SteraMist™ solutions from its customer the Caja del Seguro Social (CCS), Panama's Social Security program that provides healthcare to almost 90% of the country's population.
Dr. Jaime Aleman Diaz, Director of the CCS, stated: "CCS has been using TOMI's SteraMist™ technology for decontamination services since August 2012. During this time, its efficacy in the public healthcare environment has outperformed our expectations. TOMI's SteraMist™ sterilizes surfaces in a shorter time, allowing protocols to be performed on a daily basis in tandem with our healthcare staff. TOMI's solution has produced verifiable results, helping patients and dramatically reducing the overall costs of managing Hospital Associated Infections (HAIs). Due to these positive results, we have plans to place an order for TOMI's SteraMist™ to service an additional six hospitals within our network."
Dr. Halden Shane, TOMI's Chief Executive Officer, stated: "In our work with the CCS, TOMI responded to an alarming increase in hospital infections and implemented a cleaning and disinfecting protocol using SteraMist™ at the country's largest hospital. It was determined that SteraMist™ significantly reduced the presence of various bacteria on critical hospital surfaces and medical equipment including ventilators, demonstrating the significant benefit TOMI's solutions can have if implemented and standardized throughout all major public medical facilities in the country. We are excited to continue working with the CCS as well as leveraging our recent EPA registration for hospital disinfection to add new customers around the world."
By 2010, healthcare facilities within the CCS system had high rates of infection. The traditional cleaning procedures in these facilities were not enough to significantly lower the threat of such infection and, as such, the CCS began evaluating new technology solutions. In 2012, TOMI began working with the CCS to begin a pilot program consisting of a three-month testing period with SteraMist™. Following the successful program, the CCS and TOMI signed a three-year contract for decontamination services at the Complejo Hospitalario Metropolitano (CHMDRAAM), Panama's largest hospital infrastructure managing in excess of 1,800 patients per year.
The use of SteraMist™ demonstrated the following results.
- Achieved a six-log kill.
- Left no residue or corrosive material in mechanical instruments.
- Eliminated the MDRO series that were originally found on surfaces within the facility.
- Reported zero infections associated with medical devices within Intensive Care Units (ICUs), a number the hospital had not previously achieved.
- Achieved 10 months with no infections in the neonatal area.
- SteraMist™ helped establish a 75% reduction in infection rates from prior years.
- Generated savings of tens of millions of dollars and saved more than 100 lives over two years of TOMI's decontamination services.
About TOMI™ Environmental Solutions, Inc.
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology® (BIT™) , a state of the art technology for the production of its healthcare-hospital disinfectant mist/fog represented by the TOMI™ SteraMist™ brand.
TOMI's products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI's products and services have also been used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit www.tomiesinc.com or contact us at info@tomiesinc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.